Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials
2021 · Clinical Pharmacokinetics · 8 citations
https://doi.org/10.1007/s40262-021-00990-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
320
Citations
7
h-index
6
i10-index
Charlotte Bisgaard is an academic researcher from Novo Nordisk (Denmark). The author has contributed to research in topics: Child and Adolescent Psychosocial and Emotional Development & Attention Deficit Hyperactivity Disorder & Diabetes Management and Research. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-6461-7902Click to start Chat